LillyLucy99

Dr. Prescott Genomics Student

[LillyLucy99 @LillyLucy99]

https://t.co/wdmViCuY3q
Many discoveries can be read here on diseases such as Familial Malignant Melanoma, Retinitis pigmentosa, ADHD, Essential Tremor, Alzheimer's and more!

[LillyLucy99 @LillyLucy99]

My class and I completed a series of research projects on genetic diseases. Very interesting stuff with lots of information! Link to follow #prescottgenomics

[LillyLucy99 @LillyLucy99]

@Firesta85432276 It can definitely put the consumer at risk. I do see that there is a law against health insurances using genetic data to discriminate which is a good start! @prescottgenomics

[LillyLucy99 @LillyLucy99]

@Cuz_science_lit It is an interesting rule! I remember first hearing about it in the bioethics course I took. It is a good that there are rules like this, but I still think more is needed in different areas #prescottgenomics

[LillyLucy99 @LillyLucy99]

@_RachelAnastasi Interesting article! I was interested to see that Sweden said no to everything on table 1, while the other countries had at least one yes. I also haven't put much thought into posthumous sharing. #prescottgenomics

[LillyLucy99 @LillyLucy99]

The only type of genetic testing allowed is for scientific, judicial or medical purposes. #prescottgenomics

[LillyLucy99 @LillyLucy99]

There are many interesting laws in place to protect the consumer of genetic testing. In France, it is still illegal to order DTC genetic testing. This makes them the last country in Europe to not allow this kind of testing! https://t.co/DRprf174Dx #French23andme #genetesting

[LillyLucy99 @LillyLucy99]

This is an interesting study that shows quite a bit of hesitancy/disinterest when it comes to at home DNA tests. #presscottgenomics

[Barbara Prainsack (@[email protected]) @BPrainsack]

new paper by James W. Haze et al: "Direct-to-consumer genetic testing: Prospective users’ attitudes toward information about ancestry and biological relationships" https://t.co/Uno4KZQ3cp

[LillyLucy99 @LillyLucy99]

@Firesta85432276 It is interesting that there are so many chromosomes susceptible. I'm curious to see what else you find out! #prescottgenomics

[LillyLucy99 @LillyLucy99]

@bryanna_rizas That is very interesting Bryanna! Just another reason why exercise is so important.

[LillyLucy99 @LillyLucy99]

In this article the author discusses how retinal gene therapy shows promise in treating retinitis pigmentosa. This was the first human clinical trial done for X-linked RP! #prescottgenomics

[LillyLucy99 @LillyLucy99]

Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RP… https://t.co/gfcK9PGxYA

[LillyLucy99 @LillyLucy99]

@Cuz_science_lit @ensembl That is really cool! The variant I looked up didn't have that, so I will have to try another and take a look.

[Harvard University @Harvard]

In the paper, researchers detail how they developed virus-like particles to deliver base editors https://t.co/A8mYuqisM4

[LillyLucy99 @LillyLucy99]

While looking up genes that cause kidney cancer for #prescottgenomics I noticed ensembl also lists other diseases that this gene can cause. Very interesting how it is mostly allergy based illnesses.

[LillyLucy99 @LillyLucy99]

This is a list of diseases on @ensembl that variants on this gene is known to cause.

[LillyLucy99 @LillyLucy99]

Thanks to @23andMe it is very simple to view what genes increase your chances of showing different traits. I think it is a great tool for the average person to learn more about themselves and about genomics! #prescottgenomics

[LillyLucy99 @LillyLucy99]

Here is a screenshot of an individual's likelihood of having dimples based on their genome!

[LillyLucy99 @LillyLucy99]

This is exciting research! It would be amazing to have a treatment that keeps immune functions working while treating the cancer. #prescottgenomics

[23andMe Research @23andMeResearch]

23andMe initiated a Phase 1 clinical trial for our 1st wholly-owned investigational antibody for treatment of advanced solid tumors

23ME-00610 targets CD200R1, which was identified as a promising immuno-oncology target through our Research program (1/8)

https://t.co/fYF3mzeaJ1

[23andMe Research @23andMeResearch]

23andMe initiated a Phase 1 clinical trial for our 1st wholly-owned investigational antibody for treatment of advanced solid tumors

23ME-00610 targets CD200R1, which was identified as a promising immuno-oncology target through our Research program (1/8)

https://t.co/fYF3mzeaJ1